Elsevier, CJC publish 2011 issue of Canadian Journal of Cardiology

Elsevier and the Canadian Cardiovascular Society (CJC) announce the publication of the January/February 2011 issue of the Canadian Journal of Cardiology (CJC), the first in their partnership. This theme issue focused on atrial fibrillation includes the long-awaited Canadian Cardiovascular Society Atrial Fibrillation Guidelines.

The CCS Atrial Fibrillation Guidelines are notable for the novel grading system adopted by the CCS. These guidelines address pathophysiology and investigation, emergency management, anti-arrhythmic drug therapy, stroke prevention, catheter ablation, prevention of postoperative atrial fibrillation, and surgical procedures to control arrhythmia.

The selection of the atrial fibrillation theme reflects the intention of Editor-in-Chief Stanley Nattel, MD, to focus on important clinical problems, with particular emphasis on knowledge translation. "The term 'translational research' is generally used for the translation of original basic research to clinical application," says Dr. Nattel. "However, the concept of 'knowledge translation' is much broader, including translation of clinical and population science to clinical application, translation of novel clinical insights and concerns into priorities in bench research, and translation of guidelines into clinical practice, as well as the classical bench-to-bedside meaning," he added.

First launched in 1985, the Canadian Journal of Cardiology began as a controlled circulation journal. The Journal has matured to become the official journal of the Canadian Cardiovascular Society (CCS) and is recognized as the voice of the specialty in Canada.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
More than half of all US adults are eligible for semaglutide therapy